2010
DOI: 10.1016/j.neuropharm.2009.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

10
112
1
7

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 156 publications
(130 citation statements)
references
References 76 publications
10
112
1
7
Order By: Relevance
“…Recent studies have reported reduced GLT-1 in patients with major depression (Choudary et al, 2005;Medina et al, 2013;Oh et al, 2014) and in rat models of depression (Zink et al, 2010), suggesting that reduced glial glutamate transport activity underlies depression. In support of this view, ceftriaxone, which enhances the transcriptional activity of GLT-1 (Rothstein et al, 2005), has antidepressant effects in animal models (Mineur et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have reported reduced GLT-1 in patients with major depression (Choudary et al, 2005;Medina et al, 2013;Oh et al, 2014) and in rat models of depression (Zink et al, 2010), suggesting that reduced glial glutamate transport activity underlies depression. In support of this view, ceftriaxone, which enhances the transcriptional activity of GLT-1 (Rothstein et al, 2005), has antidepressant effects in animal models (Mineur et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Animals expressing learned helplessness showed a significantly suppressed expression of the glial glutamate transporter GLT1 (rodent nomenclature for EAAT2) in hippocampus and cerebral cortex compared with non-helpless animals and littermates with low levels of helplessness (Zink et al, 2010). Reduced glial fibrillary acidic protein (GFAP) expression is observed following chronic unpredictable stress (CUS) is associated with depressive-like behaviors in rodent models, and pharmacological treatments that attenuate the effects of CUS on of GFAP expression and/or facilitate EAAT function can reverse the cellular and behavioral effects of CUS (Banasr et al, 2010;Czeh et al, 2006;Gourley et al, 2012;Mineur et al, 2007;Sanacora and Banasr, 2013) Induction of anhedonia in laboratory animals by inhibition of astroglial surface (plasmalemmal) glutamate transporters (Bechtholt-Gompf et al, 2010;Ongur et al, 2014).…”
Section: Box 1 Examples Of Evidence Suggesting a Role For Astrocyte Pmentioning
confidence: 99%
“…psychogenetically or pharmacogenetically selected rodent strains (e.g. [9,11,[17][18][19][20][21]), may provide "depresssion" models per se, without the need of using previous exposure to predisposing factors such as stressful experiences (see further in the "Discussion").…”
Section: Introductionmentioning
confidence: 99%